SCHEMBL7227045

SCHEMBL7227045

CNC(=O)c1ccc2c(c1)C(=C(C)Nc1cccc(CN(C)C)c1)C(=O)N2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.39
RCOR1 Q9UKL0 1/20 0.39
ROCK2 O75116 3/20 0.39
KIT P10721 1/20 0.38
PDGFRA P16234 1/20 0.38
KDR P35968 1/20 0.38
AKT2 P31751 5/20 0.37
PDPK1 O15530 4/20 0.37
AKT1 P31749 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
SIRT3 Q9NTG7 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
AURKA O14965 1/20 0.36
RPS6KB1 P23443 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
BCHE P06276 2/20 0.36
PARP1 P09874 1/20 0.35
FCER2 P06734 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7227041 1.00 KDM1A (0.39) KDM1ARCOR1ROCK2KITPDGFRA
SCHEMBL6978475 0.90 MEN1 (0.40) KDM1ARCOR1ROCK2KITPDGFRA
SCHEMBL6978482 0.90 MEN1 (0.40) KDM1ARCOR1ROCK2KITPDGFRA
SCHEMBL7225609 0.89 JAK3 (0.42) KDM1ARCOR1ROCK2KITPDGFRA
SCHEMBL7225613 0.89 JAK3 (0.42) KDM1ARCOR1ROCK2KITPDGFRA
SCHEMBL7224414 0.89 ROCK2 (0.41) ROCK2AKT2PDPK1AKT1FCER2
SCHEMBL7224411 0.89 ROCK2 (0.41) ROCK2AKT2PDPK1AKT1FCER2
SCHEMBL7232079 0.87 BRD4 (0.40) KDM1ARCOR1KITPDGFRAKDR
SCHEMBL7232075 0.87 BRD4 (0.40) KDM1ARCOR1KITPDGFRAKDR
SCHEMBL7225072 0.85 KIT (0.38) KDM1ARCOR1KITPDGFRAKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545035-B1 Having effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells. BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-04-08 US disclosed
US-6319918-B1 FOR LYMPHOMA OR SOLID TUMORS TREATMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-20 US disclosed